Cite
MLA Citation
J.W. Holch et al.. “Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).” European journal of cancer, vol. 106, 2019, pp. 115–125. http://access.bl.uk/ark:/81055/vdc_100075225656.0x000029